Research Articles Library

Search tips: Keywords PMID Journal DOI or use Advanced Search for precise filtering
Literature Analysis Tools
Advanced Search

Filter by PMID, year, source, DOI and other criteria

Literature Analysis

Analyze research trends and hotspots

Batch Export

Export search results to Excel/PDF

Clinical and imaging findings in enteropathic spondyloarthritis with special emphasize in diagnostic delay: a cross-sectional study

Publication Year: 2024 Source: Ther Adv Chronic Dis PMID: 38380226 DOI: 10.1177/20406223241229843

BACKGROUND: Enteropathic spondyloarthritides (eSpAs) are chronic inflammatory joint diseases associated with inflammatory bowel disease (IBD). Limited data are available on the prevalence since arthritis in IBD patients may be underestimated because medications may hide disease activity with a possible diagnostic delay. OBJECTIVES: We aimed to evaluate diagnostic delay in eSpA …

Dissecting the genetic architecture of quantitative traits using genome-wide identity-by-descent sharing

Publication Year: 2024 Source: Mol Ecol PMID: 38380534 DOI: 10.1111/mec.17299

Additive and dominance genetic variances underlying the expression of quantitative traits are important quantities for predicting short-term responses to selection, but they are notoriously challenging to estimate in most non-model wild populations. Specifically, large-sized or panmictic populations may be characterized by low variance in genetic relatedness among individuals which, in …

Fufangxiaopi formula alleviates DSS-induced colitis in mice by inhibiting inflammatory reaction, protecting intestinal barrier and regulating intestinal microecology

Publication Year: 2024 Source: J Ethnopharmacol PMID: 38380568

ETHNOPHARMACOLOGICAL RELEVANCE: Fufangxiaopi Formula (FF) is a modified form of Sishen Wan, traditionally used for treating diarrhea. The application of FF for treating ulcerative colitis (UC) has achieved desirable outcomes in clinical settings. However, the underlying mechanism of the effect of FF on UC is yet to be determined. AIM …

Therapeutic drug monitoring of vedolizumab therapy in inflammatory bowel disease

Publication Year: 2024 Source: J Gastroenterol Hepatol PMID: 38380724

No Abstract

Low-FODMAP diet and hidradenitis suppurativa: the role of nutritionists in the management of dermato-endocrine disorders

Publication Year: 2024 Source: Minerva Endocrinol (Torino) PMID: 38381473

No Abstract

A tailored series of engineered yeasts for the cell-dependent treatment of inflammatory bowel disease by rational butyrate supplementation

Publication Year: 2024 Source: Gut Microbes PMID: 38381494 DOI: 10.1080/19490976.2024.2316575

Intestinal microbiota dysbiosis and metabolic disruption are considered essential characteristics in inflammatory bowel disorders (IBD). Reasonable butyrate supplementation can help patients regulate intestinal flora structure and promote mucosal repair. Here, to restore microbiota homeostasis and butyrate levels in the patient's intestines, we modified the genome of Saccharomyces cerevisiae to produce …

UCFNNet: Ulcerative colitis evaluation based on fine-grained lesion learner and noise suppression gating

Publication Year: 2024 Source: Comput Methods Programs Biomed PMID: 38382306

No Abstract

Prediction of response to anti-TNFα using integrative computational approaches in Crohn's disease-Needle in a haystack or a promising biomarker?

Publication Year: 2024 Source: Cell Rep Med PMID: 38382470

No Abstract

Clinical factors associated with severity in patients with inflammatory bowel disease in Brazil based on 2-year national registry data from GEDIIB

Publication Year: 2024 Source: Sci Rep PMID: 38383742 DOI: 10.1038/s41598-024-54332-1

The Brazilian Organization for Crohn's Disease and Colitis (GEDIIB) established a national registry of inflammatory bowel disease (IBD). The aim of the study was to identify clinical factors associated with disease severity in IBD patients in Brazil. A population-based risk model aimed at stratifying the severity of IBD based on …

IL-10 constrains sphingolipid metabolism to limit inflammation

Publication Year: 2024 Source: Nature PMID: 38383790

No Abstract

98453 Results
Page of
9846 Pages
Need more literature?

The current database contains 98453 research articles. If you need to search for more literature or perform AI analysis, please use our knowledge acquisition module or explore external literature resources.

Knowledge Acquisition Module: Upload and analyze your own literature files
External Resources: Access comprehensive literature databases worldwide